Chicago Partners Investment Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Chicago Partners Investment Group LLC

  • $2.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$543.48 - $670.97 $196,739 - $242,891
-362 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $207,798 - $246,507
362 New
362 $219,000
Q3 2020

Nov 06, 2020
SELL
$544.75 - $658.21 $235,876 - $285,004
-433 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$493.32 - $643.92 $213,607 - $278,817
433 New
433 $276,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email